Lucie-Marie Scailteux

14PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsDental therapeutics, pharmacology and toxicologyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 17, 2025
Second primary cancers and hormonal therapies for prostate cancer: A nested case-control study.

Lucie-Marie Scailteux, Julien Bezin, Marion Gundelwein

|May 01, 2023
Pharmacokinetic Interactions Between Abiraterone, Apalutamide, Darolutamide or Enzalutamide and Antithrombotic Drugs: Prediction of Clinical Events and Review of Pharmacological Information.

François Boujonnier, Florian Lemaitre, Lucie-Marie Scailteux

|Mar 22, 2023
Osteonecrosis of the jaw under palbociclib: A case series description.

Chabnam Yosofi, Sophie Cairon-Lejeune, Claudia Lefeuvre-Plesse

|Sep 21, 2022
Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case-time control study and a nested case-control study based on the French national health insurance (SNDS) cohort.

Pauline Berthe, Lucie-Marie Scailteux, Alain Lescoat

|Jul 05, 2021
Hospitalization for adverse events under abiraterone or enzalutamide exposure in real-world setting: A French population-based study on prostate cancer patients.

Lucie-Marie Scailteux, Fabien Despas, Frédéric Balusson

|Jun 17, 2021
Changes in prostate cancer screening practice by blood PSA testing between 2011 and 2017, a French population-based study.

Lucie-Marie Scailteux, Valérian Capelle, Frédéric Balusson

Pageof 3

Frequent Collaborators

4 joint publications

Emmanuel Oger

1 joint publications

Gincy George

1 joint publications

Viviane Kovess-Masfety

1 joint publications

Frédéric Balusson